176 related articles for article (PubMed ID: 9065319)
1. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.
Nordberg A; Lundqvist H; Hartvig P; Andersson J; Johansson M; Hellstrŏm-Lindahi E; Långström B
Dement Geriatr Cogn Disord; 1997; 8(2):78-84. PubMed ID: 9065319
[TBL] [Abstract][Full Text] [Related]
2. In vivo detection of neurotransmitter changes in Alzheimer's disease.
Nordberg A
Ann N Y Acad Sci; 1993 Sep; 695():27-33. PubMed ID: 7902055
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.
Nordberg A
Acta Neurol Scand Suppl; 1993; 149():62-5. PubMed ID: 8128843
[TBL] [Abstract][Full Text] [Related]
4. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.
Nordberg A; Lilja A; Lundqvist H; Hartvig P; Amberla K; Viitanen M; Warpman U; Johansson M; Hellström-Lindahl E; Bjurling P
Neurobiol Aging; 1992; 13(6):747-58. PubMed ID: 1491741
[TBL] [Abstract][Full Text] [Related]
5. PET studies and cholinergic therapy in Alzheimer's disease.
Nordberg A
Rev Neurol (Paris); 1999; 155 Suppl 4():S53-63. PubMed ID: 10637939
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic therapy in dementia.
Whitehouse PJ
Acta Neurol Scand Suppl; 1993; 149():42-5. PubMed ID: 8128838
[TBL] [Abstract][Full Text] [Related]
7. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
Kadir A; Darreh-Shori T; Almkvist O; Wall A; Långström B; Nordberg A
Psychopharmacology (Berl); 2007 May; 191(4):1005-14. PubMed ID: 17310387
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies in Alzheimer patients with positron emission tomography.
Nordberg A
Behav Brain Res; 1993 Nov; 57(2):215-24. PubMed ID: 7906947
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat.
Zhang X; Tian JY; Svensson AL; Gong ZH; Meyerson B; Nordberg A
J Neural Transm (Vienna); 2002 Mar; 109(3):377-92. PubMed ID: 11956958
[TBL] [Abstract][Full Text] [Related]
10. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities.
Nordberg A; Amberla K; Shigeta M; Lundqvist H; Viitanen M; Hellström-Lindahl E; Johansson M; Andersson J; Hartvig P; Lilja A; Långström B; Winblad B
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):228-37. PubMed ID: 9772028
[TBL] [Abstract][Full Text] [Related]
11. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
[TBL] [Abstract][Full Text] [Related]
12. 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) acts on the brain muscarinic and nicotinic cholinergic receptors as evaluated by positron emission tomography (PET) in rhesus monkey.
Tani Y; Ishihara T; Kanai T; Ohno T; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P; Långström B
Adv Exp Med Biol; 1993; 338():331-4. PubMed ID: 8304132
[No Abstract] [Full Text] [Related]
13. Biphasic effect of tacrine on acetylcholine release in rat brain via M1 and M2 receptors.
Svensson AL; Zhang X; Nordberg A
Brain Res; 1996 Jul; 726(1-2):207-12. PubMed ID: 8836562
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
Lemière J; Van Gool D; Dom R
Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
Kadir A; Almkvist O; Wall A; Långström B; Nordberg A
Psychopharmacology (Berl); 2006 Nov; 188(4):509-20. PubMed ID: 16832659
[TBL] [Abstract][Full Text] [Related]
16. A novel anticholinesterase THB013: biochemical and behavioural studies.
Adem A; Mohammed AH; Winblad B; Henriksson BE
J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):139-48. PubMed ID: 7893376
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.
Nordberg A; Lundqvist H; Hartvig P; Lilja A; Långström B
Alzheimer Dis Assoc Disord; 1995; 9(1):21-7. PubMed ID: 7605618
[TBL] [Abstract][Full Text] [Related]
18. Inhibition mechanism of rat α₃β₄ nicotinic acetylcholine receptor by the Alzheimer therapeutic tacrine.
Cheffer A; Ulrich H
Biochemistry; 2011 Mar; 50(11):1763-70. PubMed ID: 21247200
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of cholinesterase inhibitors in Alzheimer's disease.
Håkansson L
Acta Neurol Scand Suppl; 1993; 149():7-9. PubMed ID: 7907455
[TBL] [Abstract][Full Text] [Related]
20. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
